IMLFF Stock, InMed Pharmaceuticals Inc. Information

lt p gt InMed Pharmaceuticals Inc. is a pre clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid based therapies to treat human diseases with high unmet medical needs. The Company has three core assets: a proprietary Bioinformatics assessment tool to match individual or combination of cannabinoids against disease targets a proprietary Biosynthesis cannabinoid manufacturing system to economically produce all cannabinoids at pharmaceutical grade gt . purity and drug development program enabled by the two aforementioned tools. Leaders in the pipeline include a treatment for the symptoms and, potentially, the underlying disease in Epidermolysis Bullosa, a rare, devastating genetic skin disorder and, a once a day eyedrops formulation of cannabinoids to treat Glaucoma, one of the leading causes of blindness in the developed world.